Skip to main navigation Skip to search Skip to main content

Tolerance to SARS-CoV-2 mRNA Vaccination in a Patient With Challenge-Confirmed PEG 2000 Allergy

  • Technical University of Munich

Research output: Contribution to journalComment/debate

10 Scopus citations
Original languageEnglish
Pages (from-to)149-150
Number of pages2
JournalJournal of Investigational Allergology and Clinical Immunology
Volume33
Issue number2
DOIs
StatePublished - 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Anaphylaxis
  • COVID-19
  • Polyethylene glycol
  • SARS-CoV-2
  • mRNA vaccine

Cite this